Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Treating pulmonary arterial hypertension: current treatments and future prospects.

Raja SG, Raja SM.

Ther Adv Chronic Dis. 2011 Nov;2(6):359-70. doi: 10.1177/2040622311420773.

2.

Therapeutic targets in pulmonary arterial hypertension.

Rhodes CJ, Davidson A, Gibbs JS, Wharton J, Wilkins MR.

Pharmacol Ther. 2009 Jan;121(1):69-88. doi: 10.1016/j.pharmthera.2008.10.002. Epub 2008 Oct 28. Review.

PMID:
19010350
3.

Targeted therapies in pulmonary arterial hypertension.

Montani D, Chaumais MC, Guignabert C, Günther S, Girerd B, Jaïs X, Algalarrondo V, Price LC, Savale L, Sitbon O, Simonneau G, Humbert M.

Pharmacol Ther. 2014 Feb;141(2):172-91. doi: 10.1016/j.pharmthera.2013.10.002. Epub 2013 Oct 14. Review.

PMID:
24134901
4.

[Novel concepts in the pathobiology of pulmonary arterial hypertension].

Rosenkranz S.

Dtsch Med Wochenschr. 2008 Oct;133 Suppl 6:S167-9. doi: 10.1055/s-0028-1091229. Epub 2008 Sep 23. Review. German.

PMID:
18814087
5.

[Update: Preclinical developments for the treatment of pulmonary arterial hypertension].

Janssen W, Ghofrani HA, Weissmann N, Grimminger F, Schermuly RT.

Dtsch Med Wochenschr. 2009 Aug;134 Suppl 5:S157-9. doi: 10.1055/s-0029-1225313. Epub 2009 Aug 28. Review. German.

PMID:
19718604
6.

Phosphodiesterase type 5 inhibitors in pulmonary arterial hypertension.

Montani D, Chaumais MC, Savale L, Natali D, Price LC, Jaïs X, Humbert M, Simonneau G, Sitbon O.

Adv Ther. 2009 Sep;26(9):813-25. doi: 10.1007/s12325-009-0064-z. Epub 2009 Sep 19. Review.

PMID:
19768639
7.

Current therapeutics and practical management strategies for pulmonary arterial hypertension.

Agarwal R, Gomberg-Maitland M.

Am Heart J. 2011 Aug;162(2):201-13. doi: 10.1016/j.ahj.2011.05.012. Epub 2011 Jul 13. Review.

PMID:
21835279
8.

Endothelial cell dysfunction and cross talk between endothelium and smooth muscle cells in pulmonary arterial hypertension.

Humbert M, Montani D, Perros F, Dorfmüller P, Adnot S, Eddahibi S.

Vascul Pharmacol. 2008 Oct-Dec;49(4-6):113-8. doi: 10.1016/j.vph.2008.06.003. Epub 2008 Jun 20. Review.

PMID:
18606248
9.

Existing drugs and agents under investigation for pulmonary arterial hypertension.

Sharma M, Pinnamaneni S, Aronow WS, Jozwik B, Frishman WH.

Cardiol Rev. 2014 Nov-Dec;22(6):297-305. doi: 10.1097/CRD.0000000000000035. Review.

PMID:
25098201
10.

Endothelin receptor antagonism in pulmonary arterial hypertension--a role for selective ET(A) inhibition?

Jacobs A, Preston IR, Gomberg-Maitland M.

Curr Med Res Opin. 2006 Dec;22(12):2567-74. Review.

PMID:
17166339
11.

Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension.

Yamanaka R, Otsuka F, Nakamura K, Yamashita M, Otani H, Takeda M, Matsumoto Y, Kusano KF, Ito H, Makino H.

Hypertens Res. 2010 May;33(5):435-45. doi: 10.1038/hr.2010.16. Epub 2010 Feb 26.

PMID:
20186146
12.

Management of dyspnea in advanced pulmonary arterial hypertension.

Sajkov D, Petrovsky N, Palange P.

Curr Opin Support Palliat Care. 2010 Jun;4(2):76-84. doi: 10.1097/SPC.0b013e328338c1e0. Review.

PMID:
20407377
13.

Emerging therapies for the treatment of pulmonary hypertension.

Stenmark KR, Rabinovitch M.

Pediatr Crit Care Med. 2010 Mar;11(2 Suppl):S85-90. doi: 10.1097/PCC.0b013e3181c76db3. Review.

PMID:
20216170
14.

Pulmonary arterial hypertension: pathobiology, diagnosis, treatment, and emerging therapies.

Rosenblum WD.

Cardiol Rev. 2010 Mar-Apr;18(2):58-63. doi: 10.1097/CRD.0b013e3181cd2c9e. Review.

PMID:
20160529
15.

[Update: Current clinical developments in pulmonary hypertension].

Dumitrescu D, Ghofrani HA, Grimminger F, Hoeper MM, Rosenkranz S.

Dtsch Med Wochenschr. 2009 Aug;134 Suppl 5:S160-3. doi: 10.1055/s-0029-1225314. Epub 2009 Aug 28. Review. German.

PMID:
19718605
16.

Current therapy of pulmonary hypertension.

Baumhäkel M, Cremers B, Böhm M.

Herz. 2005 Jun;30(4):303-10. Review.

PMID:
15965807
17.

Emerging treatments for pulmonary arterial hypertension.

O'Callaghan DS.

Clin Respir J. 2008 Jul;2(3):132-40. doi: 10.1111/j.1752-699X.2008.00059.x. Review.

PMID:
20298321
18.

The emergence of new therapeutic targets in pulmonary arterial hypertension: from now to the near future.

Malenfant S, Margaillan G, Loehr JE, Bonnet S, Provencher S.

Expert Rev Respir Med. 2013 Feb;7(1):43-55. doi: 10.1586/ers.12.83. Review.

PMID:
23362814
19.

New therapies for pulmonary arterial hypertension: an update on current bench to bedside translation.

Dewachter L, Dewachter C, Naeije R.

Expert Opin Investig Drugs. 2010 Apr;19(4):469-88. doi: 10.1517/13543781003727099. Review.

PMID:
20367190
20.

Pathobiology of pulmonary arterial hypertension.

Naeije R, Rondelet B.

Bull Mem Acad R Med Belg. 2004;159(Pt 2):219-26.

PMID:
15615096

Supplemental Content

Support Center